# Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration

> **NCT05011474** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Inbo Han** · enrollment: 4 (estimated)

## Conditions studied

- Patients With Chronic Low Back Pain Due to Degenerative Lumbar Disc

## Interventions

- **BIOLOGICAL:** administered an autologous adipose-derived mesenchymal stem cell spheroid pretreated with matrillin 3

## Key facts

- **NCT ID:** NCT05011474
- **Lead sponsor:** Inbo Han
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-23
- **Primary completion:** 2022-01-20
- **Final completion:** 2022-12-31
- **Target enrollment:** 4 (ESTIMATED)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05011474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05011474, "Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT05011474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*